Italy, Switzerland and Austria have banned the sale of anti-flu vaccines by Swiss drug-maker Novartis.
The move follows a report by Novartis of small particles in the vaccine. The pharmaceutical giant has said it is confident its flu vaccines are safe.
Anne-Claire Siegrist, President of the Swiss Vaccination Commission, said the jabs are not dangerous:
“The only potential risk, as we’ve seen in past years with the flu vaccine, is that particles can cause a slightly worse inflammation in the hours following the vaccination.”
When asked what she advises patients who have already had the vaccine, the president of the Swiss Vaccination Commission said:
“Those who’ve already been vaccinated have nothing to worry about, there is nothing to date that gives us any reason to think there is a problem. But just to be sure, we are asking doctors to wait a day or two or three until we can say, for sure, that there is nothing to worry about.”
The move comes as drug-makers are struggling to meet demand in Switzerland, where it is estimated only 1 million of 1.3 million doses ordered will be delivered.
The vaccines concerned are Agrippal, Fluad and Influpozzi.